Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops THB001, an oral small-molecule KIT inhibitor for the treatment of chronic urticaria, a dermatologic disease driven by mast cell activation that results in red, itchy, painful welts, or hives, as well as for airway and gastrointestinal tract indications. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was founded in 2019 and is headquartered in Cambridge, Massachusetts.
Third Harmonic Bio Dividend Announcement
• Third Harmonic Bio announced a quarterly dividend of $0.12 per ordinary share which will be made payable on 2014-08-15. Ex dividend date: 2014-08-06
• Third Harmonic Bio's trailing twelve-month (TTM) dividend yield is -%
Third Harmonic Bio Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2014-08-06 | $0.12 | quarterly | 2014-08-15 |
2014-05-06 | $0.12 | quarterly | 2014-05-15 |
2014-02-05 | $0.12 | quarterly | 2014-02-14 |
2013-11-06 | $0.10 | quarterly | 2013-11-15 |
2013-08-06 | $0.10 | quarterly | 2013-08-15 |
2013-05-06 | $0.05 | quarterly | 2013-05-15 |
2013-02-06 | $0.05 | quarterly | 2013-02-15 |
2012-11-06 | $0.05 | quarterly | 2012-11-15 |
2012-08-06 | $0.05 | quarterly | 2012-08-15 |
2012-05-04 | $0.05 | quarterly | 2012-05-15 |
2012-02-06 | $0.05 | quarterly | 2012-02-15 |
2011-11-04 | $0.05 | quarterly | 2011-11-15 |
2011-08-04 | $0.05 | quarterly | 2011-08-15 |
2011-05-05 | $0.05 | quarterly | 2011-05-16 |
2011-02-04 | $0.05 | quarterly | 2011-02-15 |
2010-11-04 | $0.20 | quarterly | 2010-11-15 |
2010-08-05 | $0.20 | quarterly | 2010-08-16 |
2010-05-06 | $0.20 | quarterly | 2010-05-14 |
2010-02-05 | $0.20 | quarterly | 2010-02-16 |
2009-11-05 | $0.20 | quarterly | 2009-11-16 |
2009-08-05 | $0.20 | quarterly | 2009-08-14 |
Third Harmonic Bio Dividend per year
Third Harmonic Bio Dividend growth
Third Harmonic Bio Dividend Yield
Third Harmonic Bio current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Third Harmonic Bio stock? Use our calculator to estimate your expected dividend yield:
Third Harmonic Bio Financial Ratios
Third Harmonic Bio Dividend FAQ
Other factors to consider when evaluating Third Harmonic Bio as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Third Harmonic Bio stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Third Harmonic Bio's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Third Harmonic Bio publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Third Harmonic Bio distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Third Harmonic Bio are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Third Harmonic Bio sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Third Harmonic Bio distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Third Harmonic Bio declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Third Harmonic Bio's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Third Harmonic Bio's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.